People invited to undergo fecal immunochemical testing (FIT) were more likely to participate in colorectal cancer screening compared with those invited to undergo colonoscopy, the randomized ...

A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

A University of Arizona Health Sciences-led study found that patients are more likely to get colonoscopies following abnormal ...

Combining mailed fecal immunochemical test (FIT) outreach with patient navigation significantly increased colorectal cancer (CRC) screening rates among Medicaid enrollees in rural clinics ...

A patient navigation program significantly improved the odds that people would get a colonoscopy after receiving an abnormal ...

A patient navigation program significantly increased follow-up colonoscopy among those with an abnormal FIT result. Ninety-four percent of patients who received navigation completed colonoscopy at ...

Average-risk patients can use fecal immunochemical testing (FIT) or Cologuard for a noninvasive way to screen for colon cancer, Kanth said. However, both methods have their flaws. Kanth said FIT ...

versus 71% sensitivity with fecal immunochemical test (FIT). 1 Fewer False Positives: 40% reduction compared to the original Cologuard test. 2 High Precancerous Lesion Detection: 43% sensitivity ...

A patient navigation program significantly improved the odds that people would get a colonoscopy after receiving an abnormal fecal immunochemical test result, according to a study published in ...

“We found that using patient navigators improved rates of colonoscopy follow-up and reduced time to follow-up among patients who had an abnormal fecal immunochemical test, or FIT test,” she said.